Scientific Publications from the Personalized Oncogenomics study
- Chow-White, P. et al. Knowledge, attitudes, and values amongphysicians working with clinical genomics:a survey of medical oncologists.Hum Resour Health. 2017 Jun 27;15(1):42. doi: 10.1186/s12960-017-0218-z.
- Laskin, J. et al.Clinicians identify high need to increase their genomic literacy to applied cancer genomics.Ann Oncol 2016; 27 (suppl_6): 1379P. doi: 10.1093/annonc/mdw387.16
- Weymann, D. et al. The cost and cost-trajectory of whole-genome analysis to guide treatment of patients with advanced cancer. Mol Genet Genomic Med. 2017 Mar 12;5(3):251-260. doi: 10.1002/mgg3.281
- Thibodeau, M. L. et al.Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline CHEK2:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinoma.Cold Spring Harb Mol Case Stud 2017 May 16. pii: mcs.a001628. doi: 10.1101/mcs.a001628
- Sheffield, B. S. et al.Investigation of PD-L1 Biomarker Testing Methods for PD-1 Axis Inhibition in Non-squamous Non-small Cell Lung Cancer.J Histochem Cytochem 2016 Oct;64(10):587-600. doi: 10.1369/00221554
- Sheffield, B. S. et al.Personalized oncogenomics in the management of gastrointestinal carcinomas-early experiences from a pilot study.Curr Oncol23, e571-e575, (2016) doi:10.3747/co.23.3165.
- Jones, M. R. et al.Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer.Annals of oncology : official journal of the European Society for Medical Oncology27, 801-806, doi:10.1093/annonc/mdw060 (2016).
- Alassiri AH, Ali RH, Shen Y, et al. ETV6-NTRK3 is expressed in a subset of ALK-negative inflammatory myofibroblastic tumors. Am J Surg Pathol. 2016 Aug: 40(80):1051-61
- Parker JD, Shen Y, Pleasance E, et al. Molecular etiology of an indolent lymphoproliferative disorder determined by whole-genome sequencing. Cold Spring Harb Mol Case Stud. 2016 Mar 2.
- Laskin J, Jones S, Aparicio S, et al. Lessons learned from the application of whole genome analysis to the treatment of patients with advanced cancers. Cold Spring Harb Mol Case Stud. 1: a000570. 2015 Oct 27.
- Bose P, Pleasance ED, Jones M, et al. Integrative genomic analysis of ghost cell odontogenic carcinoma. Oral Oncol. 2015 Sep;51(9):e71-5.
- Sheffield BS, Tinker AV, Shen Y, et al. Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome Sequencing. Deb S, ed. PLoS ONE. 2015;10(3):e0119689. doi:10.1371/journal.pone.0119689.
- Jamshidi F, Pleasance E, Li Y, et al. Diagnostic Value of Next-Generation Sequencing in an Unusual Sphenoid Tumor. The Oncologist. 2014;19(6):623-630. doi:10.1634/theoncologist.2013-0390.
- Jones SJ, Laskin J, Li YY, Griffith OL, An J, Bilenky M, Butterfield YS, Cezard T, Chuah E, Corbett R, Fejes AP, Griffith M, Yee J, Martin M, Mayo M, Melnyk N, Morin RD, Pugh TJ, Severson T, Shah SP, Sutcliffe M, Tam A, Terry J, Thiessen N, Thomson T, Varhol R, Zeng T, Zhao Y, Moore RA, Huntsman DG, Birol I, Hirst M, Holt RA, Marra MA. Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors. Genome Biol. 11(8):R82 (2010).
Page last modified
Oct 09, 2017